Global Iron Chelation Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Iron Chelation Therapy Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chelation therapy is a medical procedure that involves the administration of chelating agents to remove heavy metals from the body.
Iron Chelation Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Iron Chelation Therapy market is projected to reach US$ 1132.4 million in 2029, increasing from US$ 758 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Demand from Transfusional Iron Overload and NTDT Caused Iron Overload are the major drivers for the industry.
Conditions that cause iron overload, such as hereditary hemochromatosis and transfusion-dependent anemias (e.g., thalassemia, sickle cell disease), have become more prevalent, leading to an increased demand for iron chelator drugs.
Advances in diagnostic techniques and increased awareness among healthcare professionals have led to better detection and earlier diagnosis of iron overload disorders, driving the need for appropriate treatments like iron chelators.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Iron Chelation Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Novartis
Chiesi Group
Sun Pharma
Cipla
Natco Pharma
Taro Pharm
Gland Pharma
Segment by Type
Deferasirox
Deferoxamine
Deferiprone
Transfusional Iron Overload
NTDT Caused Iron Overload
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Iron Chelation Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Iron Chelation Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Iron Chelation Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Iron Chelation Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Iron Chelation Therapy introduction, etc. Iron Chelation Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Iron Chelation Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Iron Chelation Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Iron Chelation Therapy market is projected to reach US$ 1132.4 million in 2029, increasing from US$ 758 million in 2022, with the CAGR of 6.3% during the period of 2024 to 2029. Demand from Transfusional Iron Overload and NTDT Caused Iron Overload are the major drivers for the industry.
Conditions that cause iron overload, such as hereditary hemochromatosis and transfusion-dependent anemias (e.g., thalassemia, sickle cell disease), have become more prevalent, leading to an increased demand for iron chelator drugs.
Advances in diagnostic techniques and increased awareness among healthcare professionals have led to better detection and earlier diagnosis of iron overload disorders, driving the need for appropriate treatments like iron chelators.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Iron Chelation Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Novartis
Chiesi Group
Sun Pharma
Cipla
Natco Pharma
Taro Pharm
Gland Pharma
Segment by Type
Deferasirox
Deferoxamine
Deferiprone
Segment by Application
Transfusional Iron Overload
NTDT Caused Iron Overload
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Iron Chelation Therapy market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Iron Chelation Therapy, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Iron Chelation Therapy industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Iron Chelation Therapy in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Iron Chelation Therapy introduction, etc. Iron Chelation Therapy Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Iron Chelation Therapy market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.